Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Akhil Chopra"'
Publikováno v:
Indian Journal of Psychological Medicine, Vol 39, Iss 3, Pp 342-346 (2017)
Background: Anxiety and depressive disorders belong to the most common psychiatric disorders worldwide. They are generally seen in individuals who suffer from chronic diseases, such as diabetes mellitus (DM). The prevalence of depression among diabet
Externí odkaz:
https://doaj.org/article/1aac360a94194f329f45dae297a82ad7
Autor:
Akash Verma, Soon Keng Goh, Dessmon Y.H. Tai, Ai Ching Kor, Chun Ian Soo, Debra G.F. Seow, Zin Nge Nge Sein, Jens Samol, Akhil Chopra, John Abisheganaden
Publikováno v:
ERJ Open Research, Vol 4, Iss 2 (2018)
Patients with central airway obstruction (CAO) from advanced lung cancer present with significant morbidity and are assumed to have lower survival. Hence, they are offered only palliative support. We asked if patients who have advanced lung cancer wi
Externí odkaz:
https://doaj.org/article/019d843b8bfa47a5b7aad85c4c0f4330
Autor:
PR Newswire
Publikováno v:
PR Newswire US. 07/06/2020.
Autor:
Jeeve Kanagalingam, Akhil Chopra, Min Hee Hong, Wisam Ibrahim, Antonio Villalon, Jin-Ching Lin
Publikováno v:
Oncology Reviews, Vol 11, Iss 2 (2017)
Oral mucositis (OM) is a common and often dose-limiting side effect of cancer therapy. Povidone iodine (PVP-I) formulations have been shown to decrease the incidence and severity of OM, but the relevance of these findings remains unclear. The objecti
Externí odkaz:
https://doaj.org/article/f71eadf748e0442d84d551c80da8dce1
Autor:
Wei Liu, Bin Tean Teh, Akhil Chopra, Jing H. Hong, Jee K. Low, Shane Goh, Arnoud Boot, Xiaoying Xu, Vikneswari Rajasegaran, Elizabeth Lee, Choon Kiat Ho, Chung Y. Chan, Alex Y. Chang, Lavina D. Bharwani, Gilberto Lopes, Jason Yongsheng Chan, Kui H. Liau, Jing Y. Lee, Cedric Chuan Young Ng, Peng C. Cheow, Chee-Kiat Tan, Steven G. Rozen, Abner Herbert Lim, Alexander Y. F. Chung, Winston Woon
Publikováno v:
Liver Cancer International. 1:25-35
Autor:
Yee Chao, Huanyu Zhao, Chiun Hsu, Ryoko Kuromatsu, Jeffrey Anderson, Winnie Yeo, Christine Dela Cruz, Ming-Mo Hou, Akhil Chopra, Tae You Kim, Michihisa Moriguchi, Yoon-Koo Kang, Su Pin Choo, Masafumi Ikeda, Thomas Yau, Kazushi Numata, Masatoshi Kudo
Publikováno v:
Ann Transl Med
Background & Aims Nivolumab, an immune checkpoint inhibitor, is approved in several countries to treat sorafenib-experienced patients with HCC, based on results from the CheckMate 040 study (NCT01658878). Marked differences exist in HCC clinical pres
Autor:
Marina Chiara Garassino, Byoung-Chul Cho, Joo-Hang Kim, Julien Mazières, Johan Vansteenkiste, Hervé Lena, Jesus Corral Jaime, Jhanelle E Gray, John Powderly, Christos Chouaid, Paolo Bidoli, Paul Wheatley-Price, Keunchil Park, Ross A Soo, Yifan Huang, Catherine Wadsworth, Phillip A Dennis, Naiyer A Rizvi, Luis Paz-Ares Rodriguez, Silvia Novello, Sandrine Hiret, Peter Schmid, Eckart Laack, Raffaele Califano, Makoto Maemondo, Sang-We Kim, Jamie Chaft, David Vicente Baz, Thierry Berghmans, Dong-Wan Kim, Veerle Surmont, Martin Reck, Ji-Youn Han, Esther Holgado Martin, Cristobal Belda Iniesta, Yuichiro Oe, Antonio Chella, Akhil Chopra, Gilles Robinet, Hector Soto Parra, Michael Thomas, Parneet Cheema, Nobuyuki Katakami, Wu-Chou Su, Young-Chul Kim, Juergen Wolf, Jong-Seok Lee, Hideo Saka, Michele Milella, Inmaculada Ramos Garcia, Anne Sibille, Takashi Yokoi, Eun Joo Kang, Shinji Atagi, Ernst Spaeth-Schwalbe, Makoto Nishio, Fumio Imamura, Nashat Gabrail, Remi Veillon, Sofie Derijcke, Tadashi Maeda, Dylan Zylla, Kendra Kubiak, Armando Santoro, Ma. Noemi Uy, Sarayut Lucien Geater, Antoine Italiano, Dariusz Kowalski, Fabrice Barlesi, Yuh-Min Chen, David Spigel, Busyamas Chewaskulyong, Ramon Garcia Gomez, Rosa Alvarez Alvarez, Chih-Hsin Yang, Te-Chun Hsia, Fabrice Denis, Hiroshi Sakai, Mark Vincent, Koichi Goto, Joaquim Bosch-Barrera, Glen Weiss, Jean-Luc Canon, Christian Scholz, Massimo Aglietta, Hirotsugu Kemmotsu, Koichi Azuma, Penelope Bradbury, Ronald Feld, Abraham Chachoua, Jacek Jassem, Rosalyn Juergens, Ramon Palmero Sanchez, Albert Malcolm, Nandagopal Vrindavanam, Kaoru Kubota, Cornelius Waller, David Waterhouse, Bruno Coudert, Zsuzsanna Mark, Miyako Satouchi, Gee-Chen Chang, Christian Herzmann, Arvind Chaudhry, Selvaraj Giridharan, Paul Hesketh, Norihiko Ikeda, Ralph Boccia, Nichola Iannotti, Missak Haigentz, John Reynolds, John Querol, Kazuhiko Nakagawa, Shunichi Sugawara, Eng Huat Tan, Tomonori Hirashima, Scott Gettinger, Terufumi Kato, Koji Takeda, Oscar Juan Vidal, Andrea Mohn-Staudner, Amit Panwalkar, Davey Daniel, Kunihiko Kobayashi, Guia Elena Imelda Ladrera, Clemens Schulte, Martin Sebastian, Marketa Cernovska, Helena Coupkova, Libor Havel, Norbert Pauk, Joginder Singh, Shuji Murakami, Tibor Csoszi, Gyorgy Losonczy, Allan Price, Ian Anderson, Mussawar Iqbal, Vamsee Torri, Erzsebet Juhasz, Saleem Khanani, Leona Koubkova, Benjamin Levy, Ray Page, Csaba Bocskei, Lucio Crinò, David Einspahr, Christopher Hagenstad, Necy Juat, Lindsay Overton, Mitchell Garrison, Zsuzsanna Szalai
Publikováno v:
Lancet Oncology
Lancet Oncology, 2020, 19 (4), pp.521-536. ⟨10.1016/s1470-2045(18)30144-x⟩
Lancet Oncol
Lancet Oncology, 2020, 19 (4), pp.521-536. ⟨10.1016/s1470-2045(18)30144-x⟩
Lancet Oncol
Background: Immune checkpoint inhibitors are a new standard of care for patients with advanced non-small-cell lung cancer (NSCLC) without EGFR tyrosine kinase or anaplastic lymphoma kinase (ALK) genetic aberrations (EGFR−/ALK−), but clinical bene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00025c91c5f85bf7d8b98d17aae85fd1
https://hal.u-pec.fr/hal-04145965/document
https://hal.u-pec.fr/hal-04145965/document
Autor:
Divya Ghai, Akhil Chopra
Publikováno v:
Journal of Evidence Based Medicine and Healthcare, Vol 5, Iss 44, Pp 3114-3118 (2018)
BACKGROUND Attention Deficit/Hyperactivity Disorder (ADHD) is a behavioural and neurocognitive condition characterized by developmentally inappropriate and impairing levels of gross motor overactivity, inattention, and impulsivity. ADHD is often unde
Autor:
Akhil Chopra, Tim Meyer, Bruno Sangro, Jeffrey Anderson, Jörg Trojan, Ignacio Melero, Christine Dela Cruz, Anthony B. El-Khoueiry, Hao Tang, Winnie Yeo, Todd S. Crocenzi, Homa Dastani, Yoon-Koo Kang, Tae You Kim, Su Pin Choo, Lixin Lang, Chiun Hsu, Masatoshi Kudo, Thomas Yau, Theodore H. Welling, Jaclyn Neely
Publikováno v:
The Lancet. 389:2492-2502
For patients with advanced hepatocellular carcinoma, sorafenib is the only approved drug worldwide, and outcomes remain poor. We aimed to assess the safety and efficacy of nivolumab, a programmed cell death protein-1 (PD-1) immune checkpoint inhibito
Abiraterone or Enzalutamide in Advanced Castration-Resistant Prostate Cancer: An Indirect Comparison
Publikováno v:
The Prostate. 77:639-646
BACKGROUND To perform a comparative effectiveness analyses between enzalutamide and abiraterone acetate in both the pre-docetaxel and post-docetaxel settings based on published phase III randomized trials. METHODS The primary measure of efficacy was